Company

Longboard Pharmaceuticals, Inc.

Headquarters: San Diego, CA, United States

Employees: 21

CEO: Mr. Kevin R. Lind

NASDAQ: LBPH -0.02%

Market Cap

$1.36 Billion

USD as of July 1, 2024

Market Cap History

Longboard Pharmaceuticals, Inc. market capitalization over time

Evolution of Longboard Pharmaceuticals, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Longboard Pharmaceuticals, Inc.

Detailed Description

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Longboard Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: LBPH wb_incandescent

Details

Headquarters:

6154 Nancy Ridge Drive

San Diego, CA 92121

United States

Phone: 619 592 9775